Clinical Trial Update: Once-Daily Drug Regimen for HIV-Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a once-daily regimen for HIV-infected patients has completed. The trial was sponsored by the National Institute of Allergy and Infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 1 | Status: COMPLETED